12 Highest-Yielding Stocks in Bill Nygren's Extremely Profitable Portfolio
Published Mar 30, 2011 on Seeking Alpha

We have a look at value investor and guru Bill Nygren's stock holdings. Nygren runs several funds under the Oakmark Funds brand. His cumulative 10-year track record soundly beats the S&P 500. He earned returns of 74.5% to the S&P's 16.4%. Here are the highest yielding stocks in his portfolio: Glaxo Smith Kline PLC (GSK): Nygren holds nearly 1.6 million shares of Glaxo. The pharmaceutical giant is currently trading at a 35.47 P/E ratio, and offers a $2.46 (6.40%) dividend. After 18 years in a partnership with Human Genome Sciences (HGSI), GSK finally has its first reward after the FDA approved a new lupus treatment discovered by the group. The group has several treatments for other conditions still in testing. BristolMyers Squibb (BMY): Nygren holds 2.65 million shares of BristolMyers. This other pharmaceutical behemoth demonstrates resilience in its margins through inflationary quarters dating back to 1976. BMY has a market... Read more